New treatment of atrial fibrillation.
Herbert
M E
ME
Votey
S R
SR
Rutz
F
F
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage; D001281:Atrial Fibrillation / Q000150:complications / Q000188:drug therapy*; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D004077:Digoxin / Q000008:administration & dosage; D004110:Diltiazem / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D004635:Emergency Medicine / Q000639:trends; D006333:Heart Failure / Q000150:complications; D006801:Humans; D011412:Propanolamines / Q000008:administration & dosage; D014700:Verapamil / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D002121:Calcium Channel Blockers; D011412:Propanolamines; D004077:Digoxin; D014700:Verapamil; D004110:Diltiazem; C036604:esmolol